rdf:type |
|
lifeskim:mentions |
umls-concept:C0078569,
umls-concept:C0360105,
umls-concept:C0544452,
umls-concept:C0871261,
umls-concept:C1257890,
umls-concept:C1269683,
umls-concept:C1521801,
umls-concept:C1521828,
umls-concept:C1696465,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
11
|
pubmed:dateCreated |
2001-12-31
|
pubmed:abstractText |
Most examinations of the clinical efficacy of drugs used to treat depression pool subjects across gender and age groups. This investigation compared these patient subpopulations on the basis of remission and response rates associated with venlafaxine and selective serotonin reuptake inhibitor (SSRI) treatment.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0160-6689
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
869-77
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11775046-Adult,
pubmed-meshheading:11775046-Analysis of Variance,
pubmed-meshheading:11775046-Antidepressive Agents, Second-Generation,
pubmed-meshheading:11775046-Cyclohexanols,
pubmed-meshheading:11775046-Depressive Disorder, Major,
pubmed-meshheading:11775046-Female,
pubmed-meshheading:11775046-Fluoxetine,
pubmed-meshheading:11775046-Humans,
pubmed-meshheading:11775046-Male,
pubmed-meshheading:11775046-Middle Aged,
pubmed-meshheading:11775046-Randomized Controlled Trials as Topic,
pubmed-meshheading:11775046-Remission Induction,
pubmed-meshheading:11775046-Serotonin Uptake Inhibitors
|
pubmed:year |
2001
|
pubmed:articleTitle |
Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
|
pubmed:affiliation |
Wyeth-Ayerst Research, Collegeville, PA 19426, USA. entsuaA@war.wyeth.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|